Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.
Press Enter β΅ to start review
Explore by Goal
"Biology is also more important than physics, as measured by its economic consequences, by its ethical implications, or by its effects on human welfare."
- Freeman Dyson
Quick Answer
Copied
Paper in one sentence (mechanism-focused)
The authors report that, in human cancer contexts, FAM72A (but not FAM72B/C/D) binds and promotes UNG2 degradation, and that this UNG2 reduction is associated with mutagenic DNA repair outcomes, including AID-driven mutagenesis in a human SHM model.
Long Answer
FAM72A promotes UNG2 degradation and mutagenesis in human cancer cells
Reference:
Visual uses only paper-supported directionality: elevated FAM72A/B/D in tumor contexts and inverse correlation with UNG2 protein; CRISPR knockout increases UNG2; re-expression shows only FAM72A binds UNG2 and promotes UNG2 degradation; an AID induction surrogate shows reduced IgM loss in FAM72-deficient RASH1c cells.
Numeric values are taken only where the provided full-text explicitly states magnitude (e.g., β~3-fold increaseβ for UNG2 in HCT116; β2-to 3-fold higherβ for FAM72A/B over C/D in healthy tissues). The IgM loss panel is shown as directionality because the excerpt does not provide a fold-number for IgM loss change.
What they did β what they observed (paper-only)
Experiment class
Key perturbation
Main outcome
Supports which claim
Expression profiling
RT-qPCR and RNA-seq across cell lines + tissue cDNA panels
FAM72 paralogues low in most healthy tissues except thymus; FAM72A/B/D elevated in colon & breast cancers vs flanking controls
βFAM72A/B/D are cancer-associatedβ
Correlation with UNG2 protein
Stratify tumor PDX tissues by FAM72 transcripts; measure UNG2 protein by Western
Inverse correlation between FAM72 (transcripts) and UNG2 (protein)
βFAM72 may promote UNG2 degradationβ
Loss-of-function
CRISPR knockout of FAM72 (lentiviral Cas9 + gRNA; validate clones)
UNG2 protein increases upon FAM72 KO in multiple human cell lines (e.g., HCT116, Jurkat, 293T, RASH1c)
βFAM72 supports lowering UNG2 proteinβ
Functional surrogate mutagenesis
In RASH1c, doxycycline induces AID; measure IgM loss by flow
IgM loss is reduced in FAM72-deficient cells after AID induction
Re-express HA-tagged FAM72A/B/C/D in FAM72β/β HCT116 clone; normalize via GFP sorting
Only FAM72A decreases UNG2 protein levels
βFAM72A is sufficient for UNG2 degradation in humansβ
Binding mechanism
Co-IP with MG132 and Sf9 pull-down (FAM72 vs UNG2/MKLN1)
Only FAM72A robustly binds UNG2; all paralogs bind MKLN1, but UNG2 binding is FAM72A-specific
βDirect binding specificity explains why only A is functionalβ
Each row is extracted from the provided paper text describing their experiments and observed directions/magnitudes.
This is a binary visualization strictly reflecting the paperβs stated conclusion: βonly FAM72A is able to bind to and induce UNG2 degradation in human cells.β
Critique & epistemic checks (what is strong, what is uncertain)
1) Expression & correlation: supportive but not causal
The paper provides a coherent observational layer: low FAM72 in most healthy tissues (thymus exception), cancer-associated upregulation of FAM72A/B/D, and an inverse relationship between FAM72 transcript abundance and UNG2 protein levels in human cancer contexts.
However, correlation at the transcriptβprotein level does not by itself prove degradation is the dominant mechanism; it motivates but does not replace direct mechanistic experiments.
2) Mechanism: the most convincing component
The mechanistic story becomes much stronger due to: (i) loss-of-function increasing UNG2 protein across multiple human lines; (ii) paralog re-expression showing functional sufficiency only for FAM72A; and (iii) binding experiments indicating FAM72A specifically robustly interacts with UNG2 while all paralogs bind the CTLH-partner MKLN1.
3) βMutagenesisβ support: surrogate readouts, mechanistic plausibility, but missing direct mutation spectra
The strongest functional link to mutagenesis in the provided excerpt is via an SHM surrogate: doxycycline-induced AID in RASH1c with altered IgM loss when FAM72 is knocked out.
That said, the excerpt does not show direct genome-wide (or at least locus-specific) mutation spectra measurements tied to FAM72AβUNG2βuracil lesion processing in the same experimental contexts. Thus, βmutagenesisβ is supported indirectly (surrogate + UNG2 mechanism) rather than by explicit mutation quantification in this text excerpt.
4) Biases & limitations explicitly implied by the methods
Cell-line scope: conclusions are drawn from multiple established cancer/immortalized lines and PDX-derived xenograft tissue stratification, but biology may differ across tumor microenvironments and differentiation states.
Editing artifacts: CRISPR KO and lentiviral expression can introduce off-target effects or clonal idiosyncrasies; the excerpt indicates clone validation (genotyping/Sanger/qPCR/Western) but does not show rescue experiments that orthogonally restore phenotypes.
Binding assay context: Sf9 pull-downs and MG132 co-IP conditions are useful for detecting interactions/degradation propensity but are not equivalent to fully endogenous human complexes.
Mechanistic link to βAID/POBECβ in non-B cells: the paper proposes a cytosine deaminationβlinked mutagenic repair role and connects this to AID/APOBEC families, but in the excerpt provided, the direct functional demonstration is in an AID-driven SHM surrogate.
Transparency check
Data availability: raw RNA-seq in GEO accession GSE299474; other data can be requested. Competing interests: no competing financial interests generally, but βF.S is a founder and consultant for Repare Therapeutics and Induxion Therapeutics.β
This βprior workβ map is schematic, not quantitative: it points to the specific earlier mechanistic claims the paper cites regarding FAM72A/UNG2 antagonism and GID/CTLH complex-mediated UNG2 degradation, plus foundational UNG2 isoform localization.
Author reviews (one-click)
Feedback:
Updated: April 22, 2026
BGPT Paper Review
Study Novelty
70%
The paper extends a mechanistic FAM72AβUNG2 antagonism concept from prior murine/antibody-maturation contexts into human cancer cell lines and primary tumor-associated contexts, adding paralog-specific UNG2 degradation specificity (A vs B/C/D) and an AID-linked surrogate readout in a human model.
Scientific Quality
80%
Scientific quality is strengthened by converging evidence (expressionβcorrelationβmultiple knockoutsβparalog re-expressionβbinding assays). The main quality gaps (from the provided excerpt) are that βmutagenesisβ is supported via surrogate IgM loss rather than direct mutation spectra, and degradation/binding are demonstrated under experimental conditions that are not fully equivalent to endogenous human complexes.
Study Generality
60%
Generality is moderate: the mechanism is shown across several cancer cell lines and cancer tissue stratification in breast/colon contexts, but the mutagenic functional link is demonstrated through an AID surrogate in a specific SHM system.
Study Usefulness
70%
Usefulness is fairly high for mechanistic hypothesis generation: it identifies FAM72A as the paralog-specific driver for UNG2 degradation and provides experimentally testable specificity constraints (A vs B/C/D) and binding logic (UNG2 binding specificity versus MKLN1 binding).
Study Reproducibility
70%
Methods are relatively detailed (cell culture, editing approach, Western/immunoprecipitation, RNA-seq pipeline, GEO accession), supporting reproducibility. Remaining reproducibility concerns include dependence on specific cell lines and experimental conditions (e.g., MG132 co-IP; Sf9 expression) and data availability beyond GEO being available upon request.
Explanatory Depth
70%
The paper provides a reasonably deep mechanistic explanation for paralog specificity (UNG2 binding specificity) and links degradation to a DNA-repair mutagenesis model. However, explanatory depth is less complete on direct mutation-spectrum consequences in the exact human cancer settings beyond the AID surrogate.
It will download GEO GSE299474 RNA-seq, quantify FAM72AβUNG gene expression patterns across cancer cell lines, and produce correlation heatmaps and scatter plots to test whether FAM72A expression tracks UNG2 downregulation signatures.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
The idea that all FAM72 paralogues broadly antagonize UNG2 in human cancers is weakened by the paperβs re-expression and binding data showing A-specific UNG2 interaction and degradation competence.
The claim that transcript upregulation alone causally explains UNG2 protein reduction is not fully supported if protein-level inverse correlation is not accompanied by mechanistic interaction/degradation data; the paper addresses this via knockout/re-expression/binding but any remaining dependence on additional regulatory layers would need further dissection.
Quick Answer
Long Answer
Top Data Sources
ExportMCP
Keep Exploring
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Explore by Goal
Ask a Follow-Up
Key Insight
